Brief: Tandem Diabetes Care’S Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared For Pregnancy In Type 1 Diabetes
27/04/2026 14:21
April 27 (Reuters) - Tandem Diabetes Care Inc TNDM.O: TANDEM DIABETES CARE’S CONTROL-IQ+ AUTOMATED INSULIN DELIVERY TECHNOLOGY NOW FDA CLEARED FOR PREGNANCY IN TYPE 1 DIABETES Source text: ID:nBw8Wk66va Further company coverage: TNDM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tandem Diabetes Care
See all newsBrief: Tandem Diabetes Care Inc - Mark Novara, Evp And Chief Commercial Officer, To Be Terminated Without Cause - SEC Filing
Tandem Diabetes Care Q1 net loss narrows
Brief: Tandem Diabetes Care Q1 Gross Margin 55%
Brief: Tandem Diabetes Care’S Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared For Pregnancy In Type 1 Diabetes
U.S. RESEARCH ROUNDUP- Carnival, Five Below, McKesson